Releases
Found 21650 articles
Ultimate Longevity Center Sells 200 Franchises Before First Opening
Two hundred franchise territories have been claimed in just four months, signaling a massive shift in the preventive health market. Anthony Geisler’s new venture, Ultimate Longevity Center, aims to standardize the fragmented longevity industry by placing high-end clinical protocols and recovery technology into local neighborhood retail spaces.
International Paper Idles Alabama Mill After Roof Damage
Severe weather has crippled a critical roof at International Paper’s Pine Hill facility, forcing a temporary shutdown of the Alabama plant. Management shuttered the site to ensure the safety of employees and contractors as engineers evaluate the structural integrity of the damaged manufacturing hub.
Chambersburg Reenacts Its 1864 Destruction and Resilience
Confederate flames will once again appear to consume the streets of Chambersburg on July 18, as the Franklin County Visitors Bureau hosts its annual living history portrayal. The event marks the anniversary of the 1864 raid, blending somber historical reflection with a celebration of the community’s eventual rebirth from the ashes.
Citadel and Virtu Face Class Action Over Alleged Genius Group Spoofing
Investors in Genius Group Limited have launched a class action lawsuit against Citadel Securities and Virtu Americas, accusing the firms of orchestrating a widespread market manipulation scheme. The complaint alleges that the defendants utilized deceptive "spoofing" tactics to artificially influence stock prices and capture illicit trading profits.
Pomerantz LLP Launches Investigation into Primoris Services
A 50% single-day stock plunge followed by the sudden departure of its Chief Operating Officer has triggered a formal investigation into Primoris Services Corporation. New York-based Pomerantz LLP is currently examining whether the company and its leadership engaged in securities fraud or unlawful business practices following a series of downward financial revisions.
Dun & Bradstreet Integrates Business Intelligence into Cursor AI
Developers using the Cursor platform can now access the D&B Commercial Graph directly within their coding environments. By integrating verified business identity and risk data, the new plugin enables the creation of autonomous agents capable of handling complex compliance and procurement tasks with a built-in, auditable trail.
Hub Group Faces Class Action Lawsuit Following Accounting Errors
Investors who suffered losses in Hub Group, Inc. are being urged to join a class action lawsuit against the company. The legal action follows a series of disclosures regarding misstated financial reports from 2023 through 2025, which led to significant volatility in the company’s stock price earlier this year.
Pomerantz LLP Launches Investigation into Gildan Activewear
Shares of Gildan Activewear plummeted 18.7% on June 16, 2026, after a report from Jehoshaphat Research challenged the company’s financial health. The firm alleged that Gildan masked years of negative organic growth through aggressive financial engineering, prompting a formal investigation by the law firm Pomerantz LLP into potential securities fraud.
Solaris Energy Infrastructure to Join S&P SmallCap 600
Solaris Energy Infrastructure will join the S&P SmallCap 600 index on July 15, 2026, taking the spot currently held by Catalyst Pharmaceuticals. The shuffle follows the pending acquisition of Catalyst Pharmaceuticals by Angelini Pharma S.p.A., which prompted the removal of the healthcare firm from the benchmark index.
Peabody Energy Faces Class Action Over Centurion Mine Production Shortfalls
Investors who suffered losses in Peabody Energy Corporation securities now have until August 24, 2026, to seek appointment as lead plaintiff in a newly filed class action lawsuit. The litigation targets the company over alleged securities fraud tied to significant production misses at its Centurion mine earlier this year.
Pomerantz LLP Launches Investigation into Aether Holdings
Aether Holdings is facing scrutiny from the law firm Pomerantz LLP, which is probing potential securities fraud following allegations that the company operated as a sophisticated pump-and-dump scheme. The investigation centers on claims of deceptive business practices and false filings that surfaced shortly after the firm's 2025 public offering.
Medline Industries Faces Securities Fraud Investigation
A 7.16% drop in Medline Industries’ stock price has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The inquiry follows a June 2, 2026, U.S. Food and Drug Administration warning letter citing significant violations of manufacturing regulations and failures to investigate unexplained batch discrepancies at the firm.
ZoomInfo Faces Class Action Lawsuit Following Stock Price Plunge
A 32.78% drop in share price has triggered a class action lawsuit against ZoomInfo Technologies Inc. Investors who suffered losses after the company slashed its 2026 financial guidance now have until August 25, 2026, to petition the court to serve as lead plaintiff in the ongoing securities fraud litigation.
Pomerantz LLP Launches Investigation Into Identiv Following Asset Sale
Identiv shares plummeted 32% after the company announced plans to divest its Internet of Things assets and Thai subsidiary to Trackonomy Systems. The deal, which requires Identiv to contribute $25 million in cash for $50 million in preferred equity, has prompted a formal investigation by the law firm Pomerantz LLP.
Pomerantz LLP Launches Inquiry into Datavault AI Securities Practices
Investors in Datavault AI Inc. are under scrutiny as New York-based law firm Pomerantz LLP begins an investigation into potential securities fraud. The inquiry centers on allegations that the company misled shareholders regarding its core technology claims and business operations, following a damaging report from Wolfpack Research.
Pomerantz LLP Launches Investigation into ARS Pharmaceuticals
A 23.91% collapse in ARS Pharmaceuticals stock following a failed insurance coverage announcement has triggered a formal investigation by Pomerantz LLP. The firm is now examining whether the company and its leadership misled shareholders regarding the commercial prospects of its flagship nasal epinephrine spray, neffy.
Cerebras Systems Faces Investigation Following Stock Price Plunge
A 19.6% single-day stock drop has triggered a formal investigation into Cerebras Systems Inc. as legal counsel probes potential securities fraud. The inquiry follows the company’s recent quarterly report, which revealed financial results that fell significantly short of market expectations, leaving investors questioning the accuracy of earlier disclosures.
Pomerantz Law Firm Launches Hertz Global Holdings Securities Probe
Shares of Hertz Global Holdings plummeted 40.71% on June 24, 2026, after the company disclosed a $300 million private offering of exchangeable senior notes. Following the sharp market reaction, the New York-based Pomerantz LLP has opened an investigation into potential securities fraud and unlawful business practices by company leadership.
Clarins Targets Lifestyle Aging with New Double Serum Eye Formulation
Eighty-five percent of visible eye aging stems from environmental factors rather than genetics alone. Addressing this, French prestige brand Clarins is launching a new iteration of its Double Serum Eye, utilizing seven years of epigenetic research to combat the cumulative effects of pollution, fatigue, and daily habits on the eye contour.
Pomerantz LLP Launches Investigation Into Portillo’s Stock Performance
A 5.67% single-day share price drop following a sudden strategic reset has triggered a formal investigation by Pomerantz LLP. The firm is currently reviewing potential securities fraud and fiduciary breaches at Portillo's Inc., specifically targeting whether leadership misled investors regarding the company’s 2025 financial and operational growth targets.
Certara Faces Investor Investigation Following Revenue Slump
A 19 percent single-day stock drop and the abrupt departure of its finance chief have triggered a formal investigation into Certara, Inc. The Pomerantz Law Firm is now reviewing potential securities fraud claims, probing whether the company’s leadership misled investors regarding the stability of its service segment performance.
Pomerantz LLP Launches Investigation into Alamos Gold Following Stock Drop
Investors in Alamos Gold Inc. are under scrutiny by the Pomerantz Law Firm following a sharp double-digit decline in the company's share price. Legal counsel is currently examining whether the mining firm or its leadership engaged in securities fraud or unlawful business practices after disclosing significant operational setbacks.
Pomerantz LLP Launches Investigation Into NovoCure Following Trial Failure
A 20 percent single-day stock drop for NovoCure Limited has triggered a formal securities fraud investigation by Pomerantz LLP. The inquiry follows the announcement of failed Phase 3 trial results, which saw the company’s share price plummet to 14.28 dollars after the firm’s experimental glioblastoma therapy missed its primary survival endpoint.
Celsius Holdings Under Scrutiny as Pomerantz LLP Launches Investigation
Texas Attorney General Ken Paxton’s inquiry into the marketing of high-caffeine energy drinks to minors has triggered a broader legal response. New York-based Pomerantz LLP is now investigating potential securities fraud at Celsius Holdings, Inc., following accusations that the company misrepresented product safety to investors and consumers alike.
Peptide Tracker Expands to Android to Simplify Protocol Management
Kevin Miller and JP Sio have launched Peptide Tracker on the Google Play Store, offering Android users a dedicated interface for managing peptide protocols. The app eliminates the need for spreadsheets by centralizing dose logging, vial inventory, and reconstitution math into a single, ad-free mobile environment.
Labcorp Announces Quarterly Dividend of $0.72 Per Share
Labcorp Holdings Inc. has confirmed a cash dividend of $0.72 per share for its common stock, signaling a continued commitment to shareholder returns. The payment is scheduled for distribution on September 11, 2026, targeting investors who hold positions in the company by the close of business on August 28.
MSA Safety Acquires Autronica from Sentinel for $555 Million
A $555 million deal has reshaped the safety technology landscape, as Sentinel Capital Partners offloads its Norwegian fire and gas detection specialist, Autronica, to Pittsburgh-based MSA Safety. The move marks the latest exit for Sentinel, which has systematically dismantled its Spectrum Safety Solutions platform over the past several months.
Investors File Class Action Lawsuit Against Megan Holdings
A 93.4% collapse in share price on March 26, 2026, has triggered a class action lawsuit against Megan Holdings Limited. Investors who purchased securities during the company's initial public offering or subsequent months are now seeking legal recourse, alleging a coordinated stock manipulation scheme.
Pomerantz LLP Launches Investigation into JD.com Over Advertising Claims
A midyear shopping festival has triggered legal scrutiny for JD.com, as New York-based Pomerantz LLP investigates the retail giant for potential securities fraud. The inquiry follows regulatory pressure in Beijing regarding the company's marketing conduct during the widely promoted '618' event, which previously impacted the firm's American Depositary Receipt price.
Pomerantz LLP Probes Starfighters Space Following Executive Exit
A sharp 14.57% drop in Starfighters Space stock has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The inquiry follows the sudden February resignation of founder Rick Svetkoff and his spouse, Brenda Svetkoff, who both cited irreconcilable disagreements with the company’s board over core operational policies.